L-Acetylcarnitine in dysthymic disorder in elderly patients: A double-blind, multicenter, controlled randomized study vs. fluoxetine

European Neuropsychopharmacology

Volumn 23, Issue 10, 2013, Pages 1219-1225

  Bersani, Giuseppe ^a   Meco, Giuseppe ^a   Denaro, Alessandro ^c   Liberati, Damien ^a   Colletti, Chiara ^a   Nicolai, Raffaella ^b   Bersani, Francesco Saverio ^a   Koverech, Aleardo ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Sigma Tau SpA   (Italy)

^c Istituto Chirurgico Ortopedico Traumatologico (ICOT)   (Italy)

Author keywords

Dysthymic Disorder; Fluoxetine; L Acetylcarnitine

Indexed keywords

FLUOXETINE; LEVACECARNINE;

AGED; AGITATION; AKATHISIA; ANOREXIA; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL OBSERVATION; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSTHYMIA; ELDERLY CARE; EXCITEMENT; FEMALE; HAMILTON SCALE; HEADACHE; HUMAN; HYPERTENSION; HYPOTENSION; INSOMNIA; LOSS OF APPETITE; MAJOR CLINICAL STUDY; MALE; MOTOR ACTIVITY; MULTICENTER STUDY; NAUSEA; NOSE OBSTRUCTION; PRIORITY JOURNAL; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN DISEASE; SOMNOLENCE; SWEATING; TACHYCARDIA; TREATMENT DURATION; TREMOR; VISUAL IMPAIRMENT; VOMITING; XEROSTOMIA;

DYSTHYMIC DISORDER; FLUOXETINE; L-ACETYLCARNITINE;

ACETYLCARNITINE; AGED; AGED, 80 AND OVER; AGING; ANTIDEPRESSIVE AGENTS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE-BLIND METHOD; DYSTHYMIC DISORDER; FEMALE; FLUOXETINE; HUMANS; MALE; MILD COGNITIVE IMPAIRMENT; NOOTROPIC AGENTS; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; THERAPEUTIC EQUIVALENCY; TIME FACTORS;

EID: 84884292251     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2012.11.013     Document Type: Article

References (24)

1. Angelucci L., Ramacci M.T. Hypothalamo-pituitary adrenocortical function in aging: effects of acetyl-l-carnitine" In: Stress, immunity and ageing. A role for acetyl-l-carnitine 1989, 1989.
2. Bahring R., Standhardt H., Arrigoni Martelli E., Grantyn R. GABA-activated chloride currents of Postnatal mouse retinal ganglion cells are blocked by Acetylcholine and Acetylcarnitine: how specific are ion channel in immature neurons. Eur. J. Neurosci. 1994, 6:1089-1099.
3. Bella R., Biondi R., Raffaele R., Pennisi G. Effect of acetyl-l-carnitine on geriatric patients suffering from dysthymic disorders. Int. J. Clin. Pharmacol. Res. 1990, 10(6):355-360.
4. Chiechio S., Copani A., De Petris L., Morales M.E.P., Nicoletti F., Gereau R. Transcriptional regulation of metabotropic glutamate receptor 2/3 expression by the NF-kappaB pathway in primary dorsal root ganglia neurons: a possible mechanism for the analgesic effect of l-acetylcarnitine. Mol. Pain 2006, 2:20-28.
5. Chiechio S., Copani A., Zammataro M., Battaglia G., Gereau R.W., Nicoletti F. Transcriptional regulation of type-2 metabotropic glutamate receptors: an epigenetic path to novel treatments for chronic pain. Trends Pharmacol. Sci. 2010, 31(4):153-160.
6. Fulgente T., Onofrj M., Del Re M.L., Ferracci F., Bazzano S., Ghilardi M.F., Malatesta G. l-Acetylcarnitine treatment of senile depression. Clin. Trial J. 1990, 27(3):155-163.
7. Garzya G., Corallo D., Fiore A., Lecciso G., Petrelli G., Zotti C. Evaluation of the effects of l-Acetylcarnitine on senile patients suffering from depression. Drugs Exp. Clin. Res. 1990, 16(2):101-106.
8. Harsing L.G., Sershen H., Toth E., Hashim A., Ramacci M.T., Lajtha A. Acetyl-l-carnitine releases dopamine in rat corpus striatum: an in vivo microdialysis study. Eur. J. Pharmacol. 1992, 218(1):117-121.
9. Hoefer M.E., Voskanian S.J., Koob G.F., Pulvirenti L. Effects of terguride, ropinirole, and acetyl-l-carnitine on methamphetamine withdrawal in the rat. Pharmacol. Biochem. Behav. 2006, 83(3):403-409.
10. Jones L.L., McDonald D.A., Borum P.R. Acylcarnitines: role in brain. Prog. Lipid Res. 2010, 49(1):61-75.
11. Madiraju P., Pande S.V., Prentki M., Madiraju S.R. Mitochondrial acetylcarnitine provides acetyl groups for nuclear histone acetylation. Epigenetics 2009, 4:399-403.
12. Masi F., Leggio B., Nanni G., Scheggi S., De Montis M.G., Tagliamonte A., Grappi S., Gamberana C. Effects of long-term acetyl-l-carnitine administration in Rats-II: Protection against the disrupting effect of stress on the acquisition of appetitive behavior. Neuropsychopharmacology 2003, 28(4):683-693.
13. Pettegrew J.W., Levine J., McClure R.J. Acetyl-l-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression. Mol. Psychiatry 2000, 5(6):616-632.
14. 31P-MRS study of acetyl-l-carnitine treatment in geriatric depression: preliminary results. Bipolar Disord. 2002, 4(1):61-66.
15. Pisano C., Pratesi G., Laccabue D., Zumino F., Lo Giudice P., Bellocci A., Pacifici L., Camerini B., Vesci L., Castorina M., Cocuzza S., Tredici G., Marmiroli P., Nicolini G., Galbiati S., Calvani M., Carminati P., Cavaletti G. Paclitaxel and cisplatin-induced neurotoxicity: a protective role of acetyl-l-carnitine. Clin. Cancer Res. 2003, 9(15):5756-5767.
16. Pulvirenti G, Valerio C, Spadaio F, D'Agata V, Freni V, Nardo L, Drago F. Acetylcarnitine reduces the immobility of rats in a despair test. Behav. Neural Biol. 1990, 54(2):110-114.
17. Ricciolini R., Scalibastri M., Kelleher J.K., Carminati P., Calvani M., Arduini A. Role of acetyl-l-carnitine in rat brain lipogenesis: implications for polyunsaturated fatty acid biosynthesis. J. Neurochem. 1998, 71(6):2510-2517.
18. Rosca M.G., Lemieux H., Hoppel C.L. Mitochondria in the elderly: is acetylcarnitine a rejuvenator?. Adv. Drug Deliver. Rev. 2009, 61(14):1332-1342.
19. Taglialatela G., Navarra D., Cruciani R., Ramacci M.T., Alemà G.S., Angelucci L. Acetyl-l-carnitine treatment increase nerve growth factor levels and choline acetyltransferase activity in the central nervous system of aged rats. Exp. Gerontol. 1994, 29(1):55-66.
20. Tempesta E., Janiri L., Pirrongelli C. Stereospecific effects of acetylcarnitine on the spontaneous activity of brainstem neurones and their responses to acetylcholine and serotonin. Neuropharmacology 1985, 24(1):43-50.
21. Tempesta E., Casella L., Pirrongelli C., Janiri L., Calvani M., Ancona L. l-acetylcarnitine in depressed elderly subjects. A cross-over study vs placebo. Drugs Exp. Clin. Res. 1987, 13(7):417-423.
22. Tolu P., Masi F., Leggio B., Scheggi S., Tagliamonte A., De Montis M.G., Gamberana C. Effects of long-term acetyl-l-carnitine administration in rats. Increased dopamine output in mesocorticolimbic areas and protection toward acute stress exposure. Neuropsychopharmacology 2002, 27(3):410-420.
23. Valente, M., Koverech, A., Canonico, P., Grilli, M.G., 2011. Acetyl-l-carnitine, a new pharmacological modulator of adult hippocampal neurogenesis. Program no. 907.22 PosterMM29. 2011 Neuroscience Meeting Planner. Washington, DC, Society for Neuroscience, 2011, (online).
24. Zanardi R., Smeraldi E. A double-blind, randomised, controlled clinical trial of acetyl-l-carnitine vs. amisulpride in the treatment of dysthymia. Eur. Neuropsychopharm. 2006, 16(4):281-287.